A Review on Therapeutic Drug Monitoring in Pediatric Oncology

Abstract

Therapeutic drug monitoring (TDM) is advised to guarantee children's safe and efficient dosage. The objective of the study was to create and assess an external population pharmacokinetic, pathophysiological, and pharmacological underpinning for TDM in pediatric oncology. This reflects both organ-specific diseases and common pediatric cases. Methotrexate, busulfan, and asparaginase are important medications under observation. Since children's metabolisms differ, TDM helps modify the course of treatment. Finger pricks are important tactics for decreasing blood loss and predicting drug behavior in various age groups. Therapeutic Drug Monitoring in pediatric oncology supports individualized chemotherapy through analysis of pharmacokinetic differences and genetic factors.